Originally posted by StarTrekDoc
View Post
I think early treatment with a medication that inhibits the viral polymerase and viral replication (RDV) is wise especially in someone in his age group (He would have gotten RDV at my facility), and I think early treatment with a monoclonal antibody against the S protein is reasonable. In terms of discharge, if a patient is ambulating without dyspnea, and maintaining a normal room air sat, and is afebrile >24 hours, and wants to go home, and has adequate supervision (which obviously he does), AND most importantly "Looks Good", as a hospitalist that's an easy call...
Comment